| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Interim President | Interim CEO
2 companies
Schoeneck James A is a Director at Calidi Biotherapeutics, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 4 buys and 9 sells.
Estimated insider holdings value: $293K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 21, 2025 | CLDI Calidi Biotherapeutics, Inc. | Director | Buy | 75,000 | $2.00 | $150,000.00 | +6,614% | -15.3% | - | |
| Jun 30, 2025 | KYNB Fibrogen Inc | Director | Buy | 23,567 | $5.07 | $119,484.69 | +146.4% | +132.4% | - | |
| Mar 21, 2025 | KYNB Fibrogen Inc | Director | Buy | 300,000 | $0.35 | $105,040.00 | +75.5% | -27.0% | -9.5% | |
| Jun 7, 2023 | KYNB Fibrogen Inc | Director | Sell | 7,100 | $18.03 | $127,987.44 | -8.8% | -93.8% | -93.1% | |
| May 7, 2019 | KYNB Fibrogen Inc | Director | Sale+OE | 2,000 | $47.02 | $94,045.00 | -20.2% | - | - | |
| Apr 8, 2019 | KYNB Fibrogen Inc | Director | Sale+OE | 2,000 | $52.90 | $105,800.00 | -6.7% | - | - | |
| Mar 7, 2019 | KYNB Fibrogen Inc | Director | Sale+OE | 2,000 | $54.74 | $109,471.80 | -3.5% | - | - | |
| Feb 7, 2019 | KYNB Fibrogen Inc | Director | Sale+OE | 2,000 | $57.17 | $114,340.00 | -6.7% | - | - | |
| Jan 7, 2019 | KYNB Fibrogen Inc | Director | Sale+OE | 2,000 | $45.90 | $91,800.00 | -6.7% | - | - | |
| Jul 3, 2018 | KYNB Fibrogen Inc | Director | Sale+OE | 7,639 | $65.00 | $496,535.00 | -67.4% | - | - |